tradingkey.logo

BUZZ-Stephens lowers PT for Addus HomeCare amid Medicaid funding uncertainity

ReutersFeb 26, 2025 1:15 PM

Brokerage Stephens cuts price target for home health services provider Addus HomeCare ADUS.O to $142 from $153; maintains "overweight" rating

The new PT represents 45.5% upside to stock's last close

Brokerage says uncertainty over funding for federal health insurance program Medicaid has been pushing the stock lower as the co's patient population can be impacted

Stock closed 10.4% lower on Tuesday, and has shed about 22% YTD

ADUS, however, views its position of low-cost settings serving older adults and disabled population within Medicaid as likely more insulated from the broader potential reductions

Company, after market close on Monday, posted quarterly adj. profit of $1.38/shr compared with analysts' estimate $1.35/shr, according to data compiled by LSEG

11 of 12 brokerages rate the stock "buy" or equivalent, and one "underweight"; their median PT is $138 - data compiled by LSEG

ADUS rose 33.3% in 2024

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI